An Analysis Of Silexion Therapeutics Corp (NASDAQ: SLXN), And Its Business Forecast
In today’s recent session, 161.52 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) have been traded, and its beta is -0.17. Most recently the company’s